JOYTECJOYTEC CREDENTIALSCREDENTIALS QUAL STUDIESQUAL STUDIES2023
ALOPECIA AND VITILIGO (UAE, KSA, TURKEY) ALOPECIA AND VITILIGO (UAE, KSA, TURKEY)Qualitative study 60-mints N=10 Patients & N=10 Dermatologists for Alopecia Qualitative study 75-mint IDIs with N=10 Dermatologists N= 8 Dermatologists, N=2 Paediatricians, N=8 Patients & N=2 Aesthetic Clinics for Vitiligo (60-mints) with N=2 Pediatricians, N=10 Patients & N=2 Aesthetic Clinics for Alopecia and Vitiligo The study aims to map patient journey for Alopecia and Vitiligo. Phase 1 Phase 2
IN CONCERT VACCINE (KSA) IN CONCERT VACCINE (KSA)in-concert methodology N=3 HCPs and consumers.
IVF (KSA)IVF (KSA)Semi Qualitative study N=4 industry experts
HYDROLYSED RICE-BASED FORMULAS (KSA) HYDROLYSED RICE-BASED FORMULAS (KSA)Qualitative study N=4 Paediatricians and N=4 Paedia/Gastro. The study is about paediatric GI issues, use of hydrolysed rice-based formulas.
HIV (ISRAEL)HIV (ISRAEL)Qualitative study 60-mints N=15 HIV treaters, initiate ARVs, minimum patient numbers, visited by HIV rep.
DIFFUSE LARGE B-CELL LYMPHOMA (ISRAEL) DIFFUSE LARGE B-CELL LYMPHOMA (ISRAEL)Qualitative research 90-mints Initial Debate Duos with N= 24 Physicians 75-mints WATDIs with N= 82 Physicians the study aims to Understand the early 2L CAR-T launch experiences of those physicians who have used / initiated / referred for CAR-T in 2L DLBCL.
JOYTECJOYTEC CREDENTIALSCREDENTIALS QUAL STUDIESQUAL STUDIES2024
MIGRAINE (UAE)MIGRAINE (UAE)Qualitative research 60-mints N=8 Neurologists & N=4 PCPs.
RECRUITMENT (KSA)RECRUITMENT (KSA)Qualitative study 60-mints N=4 Payers (2 MoH, 2 private insurers) & N=2 (Nephrologist/ Urologist/ Oncologist).
SICKLE CELL DISEASE (MIDDLE EAST) SICKLE CELL DISEASE (MIDDLE EAST)Qualitative study 60-mints N=1-2 Hematologists and Payers per country.
RSV VACCINE (KSA)RSV VACCINE (KSA)Qualitative study N=5 HCPs including Primary Care, Pulmonologist, Family Medicine / General Practice, Internal Medicine and Gerontologists & N=3 KOLs including Immunologist or Infectious Disease Specialist & N=5 Consumers.
PSO (KSA)PSO (KSA)Qualitative study N=6 Rheumatologists & N=6 Dermatologists & N=2 Payers
SICKLE CELL DISEASE (KSA) SICKLE CELL DISEASE (KSA)Qualitative study 60-mints N=1 transplanter & N=1 hematologist the study aims to identifying the unmet need for Sickle Cell Disease patients that are at risk of stroke / have a history of stroke, as well as evaluating what a minimum viable product profile would look like for that population.
XLH (WATIDIS) KSAXLH (WATIDIS) KSAQualitative study 75-mins N= 5 Endocrinologist, Nephrologist, Rheumatologist, Orthopedic surgeons/specialists Kaleidoscope HCPs Treating XLH, a mix of users and non-users of CRYSVITA.
GLAUCOMA STUDYGLAUCOMA STUDYQual sessions WATDIs 60 minutes with ophthalmologists Deliverables of this study were Screener Update + Weekly FW update + Audio files + Content Analysis.
OBESITY (2 H) STUDY KSAOBESITY (2 H) STUDY KSAQual study N=6 obese patients Patients are from different points in their treatment with GLP-1 analogue medication. Half of them with BMI=27-30 + at least one ORC, other half with BMI≥30 Investigations were made by our team to detect reasons other than financial ones, that made patients stop these medications.
SICKLE CELL DISEASE (SCD) AND / OR TRANSFUSION- DEPENDENT BETA- THALASSEMIA (TDT) (KSA) SICKLE CELL DISEASE (SCD) AND / OR TRANSFUSION- DEPENDENT BETA- THALASSEMIA (TDT) (KSA)Qual study 60-minutes N=1 apheresis physician who is Medical Directors of Apheresis Unit and Direct experience with apheresis and cell collection for SCD / TDT.
MULTIPLE SCLEROSIS UAE, KUWAIT, KSA MULTIPLE SCLEROSIS UAE, KUWAIT, KSAQual study 30-mins WATDIs with Neurologists whose primary focus on generally neurology or multiple sclerosis, American board-certified in their speciality, more than 3 years of experience, sees at least 25 multiple sclerosis patients per month.
MULTIPLE MYELOMA (UAE, KUWAIT AND KSA) MULTIPLE MYELOMA (UAE, KUWAIT AND KSA)Qual TDIs 60 mins N=5 MM Treaters – Hema-Oncs / Med- Onco doctors from UAE+Kuwait and N=3 from KSA
SCD UAE AND KSASCD UAE AND KSAQual interviews 60 mins using telephone/Zoom call Hematologists and Payers
ADVANCED RENAL CELL CARCINOMA (ARCC) KSA ADVANCED RENAL CELL CARCINOMA (ARCC) KSAQual study 60 mins WATIs + 30 mins pre-read. Payers (MoH, private insurer) and KOL (Nephrologist/ Urologist/ Oncologist).
MIGRAINE (UAE)MIGRAINE (UAE)Qual TDIs 60 mins N=8 Neuro and N=4 PCPs. Tasks managed by our team were recruitment, moderation and transcription.
PAIN INSTITUTE (KSA)PAIN INSTITUTE (KSA)Qualitative study 90 mins with N=4 GPs and 60 mins WATDIs with N=4 pharmacists. GPs (have 5+ years of experience and spend 70% of their time with patients) and pharmacists (recommend pain OTC medications). Tasks managed by our team were recruitment, moderation and transcription.
JOYTECJOYTEC CREDENTIALSCREDENTIALS QUAL STUDIESQUAL STUDIES2025
FRIEDREICH’S ATAXIA (KSA)FRIEDREICH’S ATAXIA (KSA)Qualitative study 75-min WATI N=5 specialists involved in the management of Friedreich’s Ataxia, including neurologists, cardiologists, pulmonologists, and endocrinologists.
GEOGRAPHIC ATROPHY (ISRAEL & SAUDI ARABIA GEOGRAPHIC ATROPHY (ISRAEL & SAUDI ARABIATrios Qualitative study 120 minutes N=5 Ophthalmologists and Retinal Specialists, all to prescribe intravitreal injections and treat and diagnose geographic atrophy JOYTEC tasks included recruiting doctors and conducting interviews with them. Deliverables: FW update and audio recording for all interviews. And Qualitative study (75 minutes) with (15-minute) PRFs.
BACTERIAL MENINGITIS (KSA) BACTERIAL MENINGITIS (KSA)Qualitative study 30-mints N=2 HCPs (general practitioners, pharmacists or paediatricians). The study aims to raise awareness of bacterial meningitis.
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) (KSA, UAE, ISRAEL, TURKEY) CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) (KSA, UAE, ISRAEL, TURKEY) Qualitative research N=36 HCPs (Nuerologists)
SICKLE CELL DISEASE (KSA)SICKLE CELL DISEASE (KSA) Qualitative survey 60-mints N=3 hematologists
JOYTECJOYTEC CREDENTIALSCREDENTIALS QUAL STUDIESQUAL STUDIES2025
VACCINES (THAILAND, VIETNAM) VACCINES (THAILAND, VIETNAM) Qualitative study 60-mints N=16 adult consumers for both Thailand and Vietnam Consumers recruited based on segments from a typing tool. All are open to vaccination.
VACCINES (THAILAND)VACCINES (THAILAND) Qualitative study 60-mints N=6 GPs and N=6 Pediatricians. Screening criteria includes 50% of the sample to be high prescribers of Qdenga and 50% of the sample to be low prescribers of Qdenga
THANK YOU